RK Capital Management LLC purchased a new position in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 52,200 shares of the health services provider's stock, valued at approximately $4,377,000. RK Capital Management LLC owned 0.09% of Maximus as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of MMS. NBC Securities Inc. acquired a new stake in Maximus during the 3rd quarter valued at $85,000. Arizona State Retirement System increased its position in shares of Maximus by 1.4% during the third quarter. Arizona State Retirement System now owns 17,307 shares of the health services provider's stock worth $1,292,000 after acquiring an additional 237 shares during the last quarter. Swiss National Bank lifted its stake in shares of Maximus by 1.0% in the third quarter. Swiss National Bank now owns 133,607 shares of the health services provider's stock worth $9,978,000 after acquiring an additional 1,300 shares in the last quarter. Janney Montgomery Scott LLC purchased a new position in Maximus in the third quarter valued at about $212,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Maximus by 5.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 707,799 shares of the health services provider's stock valued at $52,858,000 after purchasing an additional 35,319 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Down 0.3 %
Shares of Maximus stock traded down $0.28 during trading on Monday, reaching $85.82. The company had a trading volume of 483,586 shares, compared to its average volume of 339,217. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.53 and a current ratio of 1.53. Maximus, Inc. has a fifty-two week low of $72.39 and a fifty-two week high of $90.65. The firm's fifty day moving average is $83.02 and its 200-day moving average is $82.88. The company has a market cap of $5.22 billion, a price-to-earnings ratio of 22.52 and a beta of 0.74.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The health services provider reported $1.57 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.26. Maximus had a return on equity of 18.02% and a net margin of 4.58%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the company earned $0.80 earnings per share. Maximus's quarterly revenue was up 11.7% on a year-over-year basis. On average, analysts anticipate that Maximus, Inc. will post 5.79 EPS for the current year.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Wednesday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.40%. The ex-dividend date was Tuesday, May 14th. Maximus's dividend payout ratio (DPR) is presently 31.50%.
Analyst Ratings Changes
Separately, StockNews.com raised Maximus from a "hold" rating to a "buy" rating in a research report on Thursday, February 8th.
View Our Latest Stock Report on MMS
Maximus Profile
(Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- How to Invest in Tech Stocksand Top Tech Stocks to Consider
- Why Smartsheet Stock is an Undervalued Gem of an Investment
- What is MarketRank™? How to Use it
- The Most Upgraded Stocks After the Q1 Earnings Season
- Do ETFs Pay Dividends? What You Need to Know
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
→ The Hidden Anchor Investment of the Elite Revealed (From Colonial Metals) (Ad)
Should you invest $1,000 in Maximus right now?
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
7 Stocks to Own Before the 2024 Election
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
